Information Packs
Background information for Journalists
Press Releases
- 04 August 2008New data shows HIV therapy tipranavir (Aptivus®) is effective and well tolerated in children
- 28 April 2008European Commission grants full approval of HIV protease inhibitor, tipranavir (Aptivus®)
- 12 February 2008Boehringer Ingelheim initiates new HIV/AIDS Trial for extended release formulation of Viramune®
- 05 October 2007Aptivus® (tipranavir) capsules granted full approval by the U.S. FDA
- press release archive
Documents
- Annual Report 2007: Page 62 - PDF (4.9 MB)
- Fact sheet: HIV and Women (for non-US Media only) - PDF (80 KB)
- Backgrounder: APTIVUS® (Tipranavir) - PDF (137 KB)
- Backgrounder: VIRAMUNE® (Nevirapin) - PDF (119 KB)
- Backgrounder: HIV Epidemiology - PDF (98 KB)
Media Resources
- On demand webcast: Media roundtable "Women Living Positive", 23 July 2007 at the 2007 IAS Conference in Sydney, Australia. (for non-US Media only)
- Audiocast: Offered by the International AIDS Society (IAS) - Interview between a German HIV-specialist and a journalist about a survey amongst treatment-experienced HIV-patients. (for non-US Media only)
